[fcb5af]: / literature / by_gene / RUNX1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 33078873 10.1002/gcc.22901 2022 Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience. RUNX1
2 33368842 10.1002/gcc.22933 2022 Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia. RUNX1
3 33890726 10.1002/cjp2.211 2022 CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways. RUNX1
4 34250504 10.1158/2643-3230.BCD-20-0229 2022 Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. RUNX1
5 34325057 10.1016/j.jmoldx.2021.07.008 2022 Comparison of Two Quantitative PCR-Based Assays for Detection of Minimal Residual Disease in B-Precursor Acute Lymphoblastic Leukemia Harboring Three Major Fusion Transcripts. RUNX1
6 34348305 10.1159/000518280 2022 Cytogenetic and Fluorescence in situ Hybridization Profile of Pediatric Acute Lymphoblastic Leukemia in a University Hospital in South India. RUNX1
7 34535762 10.1038/s41375-021-01409-9 2022 ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis. RUNX1
8 34547766 10.1182/bloodadvances.2021004895 2022 Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia. RUNX1
9 34597466 10.1002/pbc.29361 2022 Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse. RUNX1
10 34601571 10.1182/blood.2021013156 2022 Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2. RUNX1
11 34617433 10.4274/tjh.galenos.2021.2021.0326 2022 Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients RUNX1
12 34698360 10.3892/ijo.2021.5274 2022 lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis. RUNX1
13 34727170 10.1182/bloodadvances.2021005522 2022 Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia. RUNX1
14 34753926 10.1038/s41408-021-00570-9 2022 Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes. RUNX1
15 34788984 10.3324/haematol.2021.279177 2022 Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials. RUNX1
16 34819303 10.1101/mcs.a006157 2022 Hi-C detects genomic structural variants in peripheral blood of pediatric leukemia patients. RUNX1
17 34871373 10.1182/blood.2021012727 2022 Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy. RUNX1
18 34902205 10.1111/cas.15239 2022 RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia. RUNX1
19 34933343 10.1182/bloodadvances.2021005634 2022 Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001. RUNX1
20 34940123 10.3390/cimb43030149 2022 Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression. RUNX1
21 34974289 10.1016/j.cancergen.2021.12.003 2022 Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21. RUNX1
22 34975010 10.1016/j.clml.2021.11.013 2022 Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia. RUNX1
23 34981432 10.1007/s12185-021-03269-6 2022 Newly diagnosed ETV6-RUNX1-positive B-acute lymphoblastic leukemia localized to the left pelvic bone marrow. RUNX1
24 34982829 10.1182/bloodadvances.2021005703 2022 A somatic UBA2 variant preceded ETV6-RUNX1 in the concordant BCP-ALL of monozygotic twins. RUNX1
25 34998786 10.1016/j.clml.2021.12.008 2022 The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia. RUNX1
26 34999180 10.1016/j.gene.2021.146132 2022 Identification of diagnosis and prognosis gene markers in B-ALL with ETV6-RUNX1 fusion by integrated bioinformatics analysis. RUNX1
27 35004601 10.3389/fpubh.2021.805757 2022 Risk Factors for Childhood Leukemia: Radiation and Beyond. RUNX1
28 35074994 10.4103/IJPM.IJPM_1154_20 2022 Erythrophagocytosis in a patient with B-cell acute lymphoblastic leukemia with t(12;21) (p13.2; q22.1); ETV6-RUNX1: Case report and review of the literature. RUNX1
29 35084434 10.1001/jamaoncol.2021.6826 2022 Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia. RUNX1
30 35114276 10.1016/j.gene.2022.146234 2022 Oncogenic Runx1-Myc axis in p53-deficient thymic lymphoma. RUNX1
31 35253299 10.1002/gcc.23036 2022 CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia. RUNX1
32 35255774 10.1080/15548627.2022.2048432 2022 TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss. RUNX1
33 35258855 10.1007/s12185-022-03315-x 2022 JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia. RUNX1
34 35290157 10.1080/10428194.2022.2047673 2022 Significance of <i>RUNX1</i> mutation in <i>BCR-ABL1</i> positive acute myeloid leukemia - a diagnostic dilemma in a young woman with persistent bleeding. RUNX1
35 35294722 10.1007/s11864-022-00963-3 2022 In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia. RUNX1
36 35379077 10.1080/10428194.2022.2057488 2022 Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. RUNX1
37 35380239 10.1007/s00277-022-04806-x 2022 The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation. RUNX1
38 35506873 10.1080/10428194.2022.2064991 2022 Apparent coexistence of <i>ETV6::RUNX1</i> and <i>KMT2A::MLLT3</i> fusions due to a nonproductive <i>KMT2A</i> rearrangement in B-ALL. RUNX1
39 35533071 10.1080/10428194.2022.2067997 2022 Familial platelet disorder due to germline exonic deletions in <i>RUNX1</i>: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium. RUNX1
40 35543621 10.1080/10428194.2022.2070913 2022 Predictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis. RUNX1
41 35562965 10.3390/ijms23094574 2022 Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia. RUNX1
42 35575404 10.1093/jnci/djac101 2022 Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia. RUNX1
43 35644195 10.7499/j.issn.1008-8830.2111108 2022 [Clinical features and prognosis of childhood B-lineage acute lymphoblastic leukemia expressing the <i>PRAME</i> gene]. RUNX1
44 35685993 10.21147/j.issn.1000-9604.2022.02.03 2022 Genomic landscape of T-cell lymphoblastic lymphoma. RUNX1
45 35865523 10.3389/fimmu.2022.868053 2022 Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice. RUNX1
46 35995457 10.1080/10428194.2022.2113524 2022 Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients. RUNX1
47 36011285 10.3390/genes13081374 2022 Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction. RUNX1
48 36045062 10.3343/alm.2023.43.1.92 2022 First Case of <i>ETV6-RUNX1</i> Fusion in Adult <i>De Novo</i> Acute Myeloid Leukemia Detected Using Targeted RNA Sequencing. RUNX1
49 31385734 10.1080/10428194.2019.1648801 2021 Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited <i>RUNX1</i> mutations without a pre-existing platelet disorder. RUNX1
50 31524018 10.1080/10428194.2019.1660975 2021 Leukemic lineage switch in a t(8;22)(p11.2;q11.2)/<i>BCR-FGFR1</i>-rearranged myeloid/lymphoid neoplasm with <i>RUNX1</i> mutation - diagnostic pitfalls and clinical management including FGFR1 inhibitor pemigatinib. RUNX1
51 31704777 10.1136/jmedgenet-2019-106339 2021 Novel phenotypes observed in patients with <i>ETV6</i>-linked leukaemia/familial thrombocytopenia syndrome and a biallelic <i>ARID5B</i> risk allele as leukaemogenic cofactor. RUNX1
52 31894899 10.1002/cyto.b.21865 2021 CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases. RUNX1
53 31944572 10.1002/cyto.b.21866 2021 CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia. RUNX1
54 31952221 10.3390/cells9010215 2021 <i>ETV6</i>/<i>RUNX1</i> Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia. RUNX1
55 32013644 10.1080/10428194.2020.1719089 2021 Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes. RUNX1
56 32091281 10.1080/10428194.2020.1723016 2021 Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated <i>RUNX1</i> versus acute myeloid leukemia with myelodysplasia-related changes with mutated <i>RUNX1</i>. RUNX1
57 32118299 10.1111/bjh.16523 2021 Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche. RUNX1
58 32150610 10.1182/bloodadvances.2019001008 2021 The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia. RUNX1
59 32276273 10.1182/blood.2019003312 2021 E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia. RUNX1
60 32368831 10.1002/gcc.22858 2021 Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16. RUNX1
61 32378810 10.1002/cam4.3099 2021 High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia. RUNX1
62 32397113 10.3390/ijms21093323 2021 Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes. RUNX1
63 32467145 10.3324/haematol.2020.247973 2021 Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. RUNX1
64 32541834 10.1038/s41423-020-0429-4 2021 Pluripotent stem cell-derived CD19-CAR iT cells effectively eradicate B-cell lymphoma in vivo. RUNX1
65 32573712 10.1182/blood.2019004090 2021 Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL. RUNX1
66 32579960 10.1016/j.bcp.2020.114116 2021 Inhibition of RUNX1 promotes cisplatin-induced apoptosis in ovarian cancer cells. RUNX1
67 32614960 10.1182/blood.2020005879 2021 Oncogenesis by E2A-PBX1 in ALL: RUNX and more. RUNX1
68 32651109 10.1016/j.clml.2020.05.020 2021 Childhood Therapy-Related Acute Myeloid Leukemia with t(16;21)(q24;q22)/RUNX1-CBFA2T3 After a Primitive Neuroectodermal Tumor of the Chest Wall. RUNX1
69 32693409 10.1182/blood.2020006164 2021 Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia. RUNX1
70 32757686 10.1080/10428194.2020.1798951 2021 Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>. RUNX1
71 32812094 10.1007/s10561-020-09855-y 2021 Screening for pre-leukemia TEL-AML1 chromosomal translocation in banked cord blood units: cord blood bank perspective. RUNX1
72 32836179 10.1016/j.anndiagpath.2020.151588 2021 Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literature. RUNX1
73 32868912 10.1038/s41423-020-00527-1 2021 Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution. RUNX1
74 32898863 10.1182/blood.2020005622 2021 Identification of functional cooperative mutations of GNAO1 in human acute lymphoblastic leukemia. RUNX1
75 32911536 10.1182/blood.2019004381 2021 An intact gut microbiome protects genetically predisposed mice against leukemia. RUNX1
76 32946981 10.1016/j.exphem.2020.09.184 2021 Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature. RUNX1
77 33038982 10.1016/j.beha.2020.101193 2021 Molecular markers in ALL: Clinical implications. RUNX1
78 33070555 10.4143/crt.2020.507 2021 Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia. RUNX1
79 33074527 10.1007/s11684-020-0759-8 2021 Precision medicine in acute lymphoblastic leukemia. RUNX1
80 33095873 10.1182/bloodadvances.2019001307 2021 Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia. RUNX1
81 33113607 10.3760/cma.j.issn.0253-2727.2020.09.008 2021 [Diagnosis of adult Philadelphia chromosome-like acute lymphoblastic leukemia by fluorescence in situ hybridization]. RUNX1
82 33161783 10.1080/10428194.2020.1832664 2021 Identification of two novel mutations in human acute myeloid leukemia cases. RUNX1
83 33164984 10.1172/JCI140797 2021 Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivo. RUNX1
84 33170547 10.1111/ijlh.13386 2021 The gene expression level of m6A catalytic enzymes is increased in ETV6/RUNX1-positive acute lymphoblastic leukemia. RUNX1
85 33225787 10.1080/10428194.2020.1849680 2021 AML1-ETO inhibits acute myeloid leukemia immune escape by CD48. RUNX1
86 33245684 10.2217/epi-2020-0152 2021 Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia. RUNX1
87 33327998 2021 [Clinical significance of minimal residual disease in B-lineage acute lymphoblastic leukemia pediatric patients with different fusion gene backgrounds]. RUNX1
88 33328584 10.1038/s41568-020-00315-z 2021 Advances in germline predisposition to acute leukaemias and myeloid neoplasms. RUNX1
89 33333691 10.3760/cma.j.issn.0253-2727.2020.11.003 2021 [Efficacy and prognostic factors of the chemotherapy regimen of CCLG-ALL-2008 on pediatric acute lymphoblastic leukemia with ETV6-RUNX1 rearrangement]. RUNX1
90 33355873 10.32471/exp-oncology.2312-8852.vol-42-no-4.15275 2021 Woman with Turner syndrome and her child with acute leukemia (a case report). RUNX1
91 33386596 10.1007/s12185-020-03063-w 2021 The role of minimal residual disease in specific subtypes of pediatric acute lymphoblastic leukemia. RUNX1
92 33400146 10.1007/s11684-020-0821-6 2021 Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia. RUNX1
93 33554816 10.19746/j.cnki.issn.1009-2137.2021.01.028 2021 [Characteristic of 8p11 Myeloproliferative Syndrome with Rare Phenotype]. RUNX1
94 33563056 10.1080/10428194.2021.1881503 2021 Searching for germline mutations in the <i>RUNX1</i> gene among Polish patients with acute myeloid leukemia. RUNX1
95 33646306 10.1182/bloodadvances.2020001844 2021 Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia. RUNX1
96 33714976 10.1038/s41375-021-01209-1 2021 Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks. RUNX1
97 33725318 10.1007/s12185-021-03116-8 2021 Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood &amp; Marrow Transplant Group Studies ALL MRD 2002 and 2008. RUNX1
98 33739852 10.1200/JCO.20.02370 2021 Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331. RUNX1
99 33743795 10.1186/s13045-021-01051-z 2021 Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia. RUNX1
100 33750258 10.1080/0284186X.2021.1900908 2021 Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on <i>BCR-ABL1</i>-like subtype. RUNX1